Attention-Deficit/Hyperactivity Disorder Patients May Have Undiagnosed Narcolepsy.

adult adhd attention deficit hyperactivity disorder (adhd) cataplexy excessive daytime sleepiness narcolepsy serum ferritin serum iron

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
04 Jun 2020
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 10 7 2020
Statut: epublish

Résumé

Background Attention-deficit/hyperactivity disorder (ADHD) patients have many comorbidities. Narcoleptic patients have a big prevalence of ADHD (15%-30%). Both groups suffer from similar symptoms and benefit from the same class of medications. As such, narcolepsy could be masked in ADHD patients. Low serum ferritin has been found both in ADHD patients as well as in patients with narcolepsy. Materials & methods We enrolled 26 participants (14 ADHD patients and 12 controls). They answered several questionnaires, and blood samples were obtained from 20 participants. We had clear exclusion criteria. Results Using the Ullanlinna Narcolepsy Scale (UNS), we identified three possible narcolepsy patients within the ADHD group and no suspects in the control group. There was a statistically significant negative correlation between serum iron levels and ADHD symptom severity. No correlation was found measuring serum ferritin levels. Conclusions Narcolepsy may be more common within ADHD patients than in the general population. Some of these patients could benefit from a change in medication. Low serum iron and ferritin levels could be relevant in ADHD pathophysiology. This requires further exploratory research.

Identifiants

pubmed: 32642351
doi: 10.7759/cureus.8436
pmc: PMC7336577
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e8436

Informations de copyright

Copyright © 2020, Wilenius et al.

Déclaration de conflit d'intérêts

The authors have declared financial relationships, which are detailed in the next section.

Références

Lancet Neurol. 2017 Mar;16(3):200-207
pubmed: 28129985
Expert Opin Pharmacother. 2017 Jun;18(8):809-817
pubmed: 28443381
Curr Psychiatry Rep. 2015 Aug;17(8):608
pubmed: 26122671
Biol Psychiatry. 2001 Aug 1;50(3):151-8
pubmed: 11513813
Child Psychiatry Hum Dev. 2016 Apr;47(2):259-69
pubmed: 26092605
Noro Psikiyatr Ars. 2017 Mar;54(1):72-77
pubmed: 28566963
Lancet. 2005 Jul 16-22;366(9481):237-48
pubmed: 16023516
Sleep. 2015 Apr 01;38(4):615-21
pubmed: 25325473
Sleep. 2005 Aug 1;28(8):1007-13
pubmed: 16218085
Sleep. 2019 Mar 1;42(3):
pubmed: 30476331
Pediatrics. 2015 Apr;135(4):e994-1001
pubmed: 25733754
Sleep. 2015 Aug 01;38(8):1285-95
pubmed: 26118560
Lancet Neurol. 2014 Jun;13(6):600-13
pubmed: 24849861
Int J Neuropsychopharmacol. 2009 Sep;12(8):1137-47
pubmed: 19580697
Arch Pediatr Adolesc Med. 2004 Dec;158(12):1113-5
pubmed: 15583094
BMC Psychiatry. 2017 Aug 22;17(1):302
pubmed: 28830387
Sleep Med. 2018 Dec;52:150-157
pubmed: 30321823
CNS Neurosci Ther. 2016 Nov;22(11):906-914
pubmed: 27255788
J Am Acad Child Adolesc Psychiatry. 1996 Aug;35(8):978-87
pubmed: 8755794
Sleep. 1998 Jun 15;21(4):371-7
pubmed: 9646381
South Med J. 2002 Jul;95(7):736-42
pubmed: 12144080
Sci Rep. 2018 Jan 15;8(1):788
pubmed: 29335588
Brain Res. 1991 Nov 1;563(1-2):227-33
pubmed: 1664773

Auteurs

Lukas Wilenius (L)

Neurology, University of Helsinki, Helsinki, FIN.

Markku Partinen (M)

Helsinki Sleep Clinic, Vitalmed Research Center, Helsinki, FIN.
Clinical Neurosciences, University of Helsinki, Helsinki, FIN.

Classifications MeSH